Product NDC: | 0093-6300 |
Proprietary Name: | Cetirizine Hydrochloride |
Non Proprietary Name: | Cetirizine Hydrochloride |
Active Ingredient(s): | 1 mg/mL & nbsp; Cetirizine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | SYRUP |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-6300 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077279 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080530 |
Package NDC: | 0093-6300-16 |
Package Description: | 473 mL in 1 BOTTLE (0093-6300-16) |
NDC Code | 0093-6300-16 |
Proprietary Name | Cetirizine Hydrochloride |
Package Description | 473 mL in 1 BOTTLE (0093-6300-16) |
Product NDC | 0093-6300 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cetirizine Hydrochloride |
Dosage Form Name | SYRUP |
Route Name | ORAL |
Start Marketing Date | 20080530 |
Marketing Category Name | ANDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | CETIRIZINE HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |